First Wave BioPharma
Caitlin Perrone, CPA, currently serves as Controller at Entero Therapeutics since March 2024. Prior to this role, Caitlin held the position of Controller at Emulate, Inc. from April 2023 to March 2024 and at Finch Therapeutics from February 2021 to February 2023, where responsibilities included overseeing financial operations. At Proteostasis Therapeutics, Inc., Caitlin progressed from SEC Reporting Manager to Senior SEC Reporting Manager between September 2018 and February 2021. Previous experience includes five years as a Senior Auditor and Staff Auditor at Wolf & Company, P.C. Caitlin holds a Master of Business Administration (MBA) with a concentration in Finance from Endicott College and a Bachelor of Arts in Accounting from Assumption University.
This person is not in any offices